EWTX Award Disclosure
Moore John R · SEC Form 4 · Filed Aug 17, 2026
Award
Calculated transaction value
$0
Moore John R General Counsel
EWTX
Transaction date
Aug 12, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 5 days later
EWTX daily price context
Close on/before transaction
$43.56
Aug 12, 2026
Close before public filing
$44.17
Aug 14, 2026
Return since public filing
+4.06%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 65,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4/A
- Filing identifier
- 0001191702-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Edgewise Therapeutics, Inc. EWTX Current | Award | Aug 12, 2026 | $0 |